PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.56%
Revenue growth under 50% of RUN's 12.90%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-41.96%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-413.65%
Negative EBIT growth while RUN is at 23.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-51.69%
Negative operating income growth while RUN is at 0.47%. Joel Greenblatt would press for urgent turnaround measures.
-198.26%
Negative net income growth while RUN stands at 460.66%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-197.56%
Negative EPS growth while RUN is at 456.14%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-197.56%
Negative diluted EPS growth while RUN is at 436.85%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.16%
Share reduction while RUN is at 1.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.16%
Diluted share reduction more than 1.5x RUN's 1.26%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
545.05%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
236.46%
FCF growth above 1.5x RUN's 156.78%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7017.95%
10Y revenue/share CAGR above 1.5x RUN's 231.43%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
92.06%
5Y revenue/share CAGR 1.25-1.5x RUN's 64.82%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
-0.79%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
5178.66%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
328.42%
Positive OCF/share growth while RUN is negative. John Neff might see a comparative advantage in operational cash viability.
21.67%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-757.62%
Negative 10Y net income/share CAGR while RUN is at 1473.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1985.35%
Negative 5Y net income/share CAGR while RUN is 1185.12%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-12189.31%
Negative 3Y CAGR while RUN is 220.80%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-27.00%
Negative 5Y equity/share growth while RUN is at 72.95%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-42.32%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.42%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-28.44%
Inventory is declining while RUN stands at 18.52%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.63%
Asset growth 1.25-1.5x RUN's 4.18%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
-11.19%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.61%
Debt growth far above RUN's 3.38%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
18.15%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
46.11%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.